These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1717145)

  • 41. Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas.
    Li H; Hamou MF; de Tribolet N; Jaufeerally R; Hofmann M; Diserens AC; Van Meir EG
    Cancer Res; 1993 Nov; 53(22):5345-9. PubMed ID: 7693337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD44 splice variants: metastases meet lymphocytes.
    Herrlich P; Zöller M; Pals ST; Ponta H
    Immunol Today; 1993 Aug; 14(8):395-9. PubMed ID: 7691067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat.
    Screaton GR; Bell MV; Bell JI; Jackson DG
    J Biol Chem; 1993 Jun; 268(17):12235-8. PubMed ID: 8509359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A PCR-based method for the analysis of human CD44 splice products.
    van Weering DH; Baas PD; Bos JL
    PCR Methods Appl; 1993 Oct; 3(2):100-6. PubMed ID: 7505677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis.
    Takeuchi K; Yamaguchi A; Urano T; Goi T; Nakagawara G; Shiku H
    Jpn J Cancer Res; 1995 Mar; 86(3):292-7. PubMed ID: 7538103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of CD44 splice variants during lymphocyte activation and tumor progression.
    Griffioen AW; Horst E; Heider KH; Wielenga VJ; Adolf GR; Herrlich P; Pals ST
    Cell Adhes Commun; 1994 Jul; 2(3):195-200. PubMed ID: 7530151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel variants of CD44 arising from alternative splicing: changes in the CD44 alternative splicing pattern of MCF-7 breast carcinoma cells treated with hyaluronidase.
    Tanabe KK; Nishi T; Saya H
    Mol Carcinog; 1993; 7(4):212-20. PubMed ID: 8352881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.
    Dougherty GJ; Landorp PM; Cooper DL; Humphries RK
    J Exp Med; 1991 Jul; 174(1):1-5. PubMed ID: 2056274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.
    Sinn HP; Heider KH; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H
    Breast Cancer Res Treat; 1995; 36(3):307-313. PubMed ID: 8573713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Participation in normal immune responses of a metastasis-inducing splice variant of CD44.
    Arch R; Wirth K; Hofmann M; Ponta H; Matzku S; Herrlich P; Zöller M
    Science; 1992 Jul; 257(5070):682-5. PubMed ID: 1496383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significance of CD44 gene products for cancer diagnosis and disease evaluation.
    Matsumura Y; Tarin D
    Lancet; 1992 Oct; 340(8827):1053-8. PubMed ID: 1357452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion.
    Hudson DL; Sleeman J; Watt FM
    J Cell Sci; 1995 May; 108 ( Pt 5)():1959-70. PubMed ID: 7544799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of CD44 splice variants in metastatic and non-metastatic mouse tumour cell lines.
    Tkach T; Li E; Bestagno M; Burrone OR
    Immunol Lett; 1996 Sep; 52(2-3):81-7. PubMed ID: 8905400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Splicing choice from ten variant exons establishes CD44 variability.
    Tölg C; Hofmann M; Herrlich P; Ponta H
    Nucleic Acids Res; 1993 Mar; 21(5):1225-9. PubMed ID: 8464707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The multispecific cell adhesion molecule CD44 is represented in reticulocyte cDNA.
    Harn HJ; Isola N; Cooper DL
    Biochem Biophys Res Commun; 1991 Aug; 178(3):1127-34. PubMed ID: 1840487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of CD44 is repressed in neuroblastoma cells.
    Shtivelman E; Bishop JM
    Mol Cell Biol; 1991 Nov; 11(11):5446-53. PubMed ID: 1922057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of tumor metastasis formation by anti-variant CD44.
    Seiter S; Arch R; Reber S; Komitowski D; Hofmann M; Ponta H; Herrlich P; Matzku S; Zöller M
    J Exp Med; 1993 Feb; 177(2):443-55. PubMed ID: 8426113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of mRNA that encodes an alternative form of H-CAM(CD44) in lymphoid and nonlymphoid tissues.
    Goldstein LA; Butcher EC
    Immunogenetics; 1990; 32(6):389-97. PubMed ID: 2272659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of CD44 abnormal transcripts in human gastric carcinomas.
    Yokozaki H; Ito R; Nakayama H; Kuniyasu H; Taniyama K; Tahara E
    Cancer Lett; 1994 Aug; 83(1-2):229-34. PubMed ID: 7520354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deranged activity of the CD44 gene and other loci as biomarkers for progression to metastatic malignancy.
    Tarin D; Matsumura Y
    J Cell Biochem Suppl; 1993; 17G():173-85. PubMed ID: 7516458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.